一个不断发展的景观:转移性结肠直肠癌的新疗法
Christiana Mo1, Bhawneet Chadha1, Chaoyuan Kuang2
1Department of Oncology, Montefiore Einstein, Bronx, NY; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY.
Clinical colorectal cancer
|September 27, 2024
概括
新型向性药物和免疫疗法在晚期结直肠癌中表现有前途. 研究正在探索最佳组合,特别是微卫星稳定疾病,以改善患者的治疗结果和生存率.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 结肠直肠癌的治疗正在通过新的向药物和免疫疗法取得进展.
- 分子标记物和瘤分析推动了这些新疗法的发展.
- 目前的治疗方法改善了生存率,但优化组合至关重要.
研究的目的:
- 审查针对晚期结直肠癌的向疗法和免疫疗法最近的临床试验数据.
- 探索结合或测序不同治疗方式的疗效.
- 研究微卫星稳定结直肠癌的潜在治疗策略.
主要方法:
- 审查最近的临床试验数据.
- 对向药物和免疫疗法的结果分析.
- 探索组合和测序策略的探索.
主要成果:
- 新型向性药物和免疫疗法在一些结肠直肠癌患者中已证明改善了无进展和整体存活率.
- 新出现的数据表明,组合疗法可能会提高疗效,特别是在微卫星稳定的结直肠癌.
- 最佳的测序和组合策略正在积极调查中.
结论:
- 针对性治疗和免疫疗法的显著进展为晚期结直肠癌提供了新的希望.
- 需要进一步的研究来确定最佳的组合和测序方法,以获得最大的患者益处.
- 改善微卫星稳定结直肠癌的治疗结果仍然是治疗发展的关键领域.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


